The University of Southern Mississippi

The Aquila Digital Community
Master's Theses
Spring 2020

Identification of Saliva Using DNA Methylation Analysis for
Forensic Use
Elizabeth Staples

Follow this and additional works at: https://aquila.usm.edu/masters_theses

Recommended Citation
Staples, Elizabeth, "Identification of Saliva Using DNA Methylation Analysis for Forensic Use" (2020).
Master's Theses. 732.
https://aquila.usm.edu/masters_theses/732

This Masters Thesis is brought to you for free and open access by The Aquila Digital Community. It has been
accepted for inclusion in Master's Theses by an authorized administrator of The Aquila Digital Community. For
more information, please contact Joshua.Cromwell@usm.edu.

IDENTIFICATION OF SALIVA USING DNA METHYLATION ANALYSIS FOR
FORENSIC USE

by
Elizabeth Staples

A Thesis
Submitted to the Graduate School,
the College of Arts and Sciences
and the School of Criminal Justice, Forensic Science, and Security
at The University of Southern Mississippi
in Partial Fulfillment of the Requirements
for the Degree of Master of Science

Approved by:
Dr. Kuppareddi Balamurugan, Committee Chair
Dr. Dean Bertram
Dr. Xuyang He

____________________
Dr. Kuppareddi
Balamurugan
Committee Chair

____________________
Dr. Lisa Nored
Director of School

May 2020

____________________
Dr. Karen S. Coats
Dean of the Graduate School

COPYRIGHT BY

Elizabeth Staples

2020

Published by the Graduate School

ABSTRACT
The identification of biological fluids is a precursor to determine if further human
identification is required in a forensic setting. There are four forensically-relevant
biological fluids: blood, semen, vaginal epithelial tissue, and saliva. While serological
testing can identify these tissue types to some degree of accuracy, there has recently been
momentum in research to use DNA methylation for tissue identification.
In the current study, five potential tissue-specific methylation markers were
studied in order to identify locations in the genome that would differentiate saliva from
other tissue types. Genomic DNA was extracted from each sample, followed by bisulfite
modification, polymerase chain reaction amplification, and pyrosequencing.
Pyrosequencing is a sequence by synthesis method that provides quantitative methylation
data. The level of significance in methylation data between tissues was calculated using
SPSS statistical package with a one-way ANOVA and Tukey’s posthoc parameters. Two
additional studies were completed: a species-specific test and mixture study.
Five loci, cg-9652652, cg-11536474, cg-3867465, cg-10781408, and cg10122865 along with several adjacent CpG sites were found to be hypermethylated in
saliva. The methylation data of saliva was statistically significant compared to other
tissues, suggesting these markers can be used to discriminate saliva from other tissue
types. In the species specificity study, it was observed that the primers used in one of the
assays were human specific as they did not amplify non-primate samples. A mixture
study using two different tissues behaved as predicted where a reduction in the
methylation percent was observed when the quantity of salivary DNA decreased.
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CHAPTER I - INTRODUCTION
Forensic DNA Identification Methods
Within the last 35 years DNA technology has seen a steady and significant
advancement, which has positively impacted the ability to identify individuals using
biological evidence materials. In 1980 Ray White describes the first polymorphic VNTR
marker; however, the use of DNA for human identification is credited to Alec Jeffreys,
who developed a Restriction Fragment Length Polymorphism (RFLP) probe in 1985 that
was able to identify variable number tandem repeat (VNTR) regions that are located
within the human genome (Butler, 2010). VNTR regions, as the name implies, are
genomic regions that contain a variable number of repeats between individuals; however,
it is because the VNTR regions vary in both number of repeats and in the number of
nucleotide bases per repeat that they are unique enough to distinguish between
individuals. Jeffreys is the first to use the RFLP technique to find VNTRs for human
identification purposes (Butler, 2010). While the RFLP probe was a huge milestone for
forensic human identification, it was not without its disadvantages. VNTR analysis
requires DNA that is non-degraded and in a quantity that is at least 100 nanograms
(Hammond et al., 1994). Neither of these factors can be guaranteed of a DNA sample
collected from a crime scene. The disadvantages of VNTR analysis prompted the search
for a human identification technique that could overcome both the high quality and
quantity barrier.
In 1983, a methodology was developed by Kary Mullis, which opened the door
for the opportunity of a more efficient way of human identification (Saiki et al., 1985).
This methodology was called polymerase chain reaction (PCR) and gave the ability to
1

amplify small quantities of DNA through successive cycles of systematic heating and
cooling. PCR involves three main steps in each cycle: denaturation, annealing, and
extension. The reaction is supplied with primers to bind single-stranded DNA, an excess
of nucleotides, DNA polymerase enzymes to extend the DNA, and buffers ideal for these
reactions to take place (Lynch & Brown, 1989). Each cycle effectively doubles the
amount of DNA present in the sample in a relatively short time span; generally,
amplification reactions take only a few hours. The ability to amplify DNA has allowed
for a large advancement in many different branches of the scientific community.
Forensically, the ability to amplify DNA gives more available sample for analysis.
Short Tandem Repeat (STR) markers contain a variable number of repeats at
different locations in the genome that are unique to each individual. The current national
DNA quality assurance standards call for the analysis of twenty STR markers for human
identification. These markers are part of the Combined DNA Index System (CODIS),
which is a DNA database maintained by the Federal Bureau of Investigation. The odds of
two individuals, excluding identical twins, having the same number of repeats at the
exact STR markers is virtually impossible. This is why STR markers have become the
method of choice when comparing evidence from a crime scene to reference samples
from the person(s) of interest. The ability to amplify DNA has allowed for the creation of
commercial kits that can amplify specific STR segments of the human genome which are
currently used for human identification (Romsos & Vallone, 2015).
Forensic Tissue Identification
While human identification has seen significant advancement in recent years,
another aspect of forensic science, serological tests, have not seen similar progress.
2

Serological tests provide information pertaining to the identity of a biological fluid found
at crime scenes. In identifying the source of the sample, the analyst can then decide what
further testing may be required. Serological tests fall within two umbrella categories:
presumptive tests and confirmatory tests. Presumptive tests are a quick means to
determining what the sample identity could be, and a confirmatory test verifies the
information gained from the presumptive test.
Currently there are several standard serological tests that are used to discriminate
between forensic tissues of interest. Two of the most commonly used presumptive blood
tests are Hemastix and the use of Phenolphthalein reagent. The presence is confirmed
using a visual examination of ferroprotoporphyrin crystals that are produced in the
presence of hemoglobin in the Takayama Crystal Test. Semen is presumptively
identified using an Acid Phosphatase reagent, and confirmed using a visual observation
of stained spermatozoa. There are also ABAcard tests for both blood and sperm,
respectively, that confirm the presence of the substance in question using antigenantibody interactions. Saliva is identified by the presence of an Amylase enzyme, which
is found in higher quantity in saliva compared to all other biological samples.
While these tests do help in the discrimination of tissue types, they are not
without fault. Currently there are no standard tests used to identify vaginal epithelial
samples. Many of the tests listed above are also not specific to human biological samples,
could result in false positives or negatives in cases where diluted samples are used, and
the serological test reagents have the potential to degrade DNA (Gonçalves et al., 2017;
Tobe et al., 2007; Vennemann et al., 2014). Some serological tests require a large
amount sample, a luxury that is not always readily available in forensic casework. Also,
3

any sample that is used up for serological testing cannot then be used for identification
purposes. This necessitates the need for a more reliable and streamlined protocol for
forensic tissue identification.
DNA Methylation for Tissue Identification
Recently, there has been evidence to support DNA methylation analysis as a
viable option for forensic tissue identification. DNA methylation is an epigenetic
modification that occurs either naturally or in response to environmental stimuli such as
age, smoking status, diet, and tissue type (Vidaki et al., 2013). In this process a methyl
group is added to a cytosine base without changing the underlying sequence of the DNA
itself (Li & Zhang, 2012). This type of modification occurs mostly in cytosine bases that
are immediately followed by guanine bases. For this reason, the sites in the genome
where this modification occurs are called CpG sites. Areas of the genome that contain a
large amount of CpG sites in close proximity are called CpG islands (Vidaki, Daniel, &
Court, 2013). Methylation levels have long been a topic of interest in the medical
community, as the proximity of these CpG islands to the promoter region of genes can
have an effect on gene activation or repression. Approximately 60% of all gene
promoters include a CpG island (Li & Zhang, 2012). When the CpG island is
unmethylated the promoter region is available for binding allowing for genes to be
transcribed, when it becomes methylated the response is generally gene inactivation
(Previti et al., 2009).
Within the last decade, however, there has been momentum in research to use
DNA methylation for forensic tissue identification. The tissue source of a biological
sample has been proven to affect the methylation level for a given sample. Therefore, the
4

main objective of this methylation-related research has been trying to find those CpG
sites that are specific for the tissue-type in question. In order to do this, a selected CpG
site must be either hypomethylated for one tissue type and hypermethylated for all others,
or vice versa. There has been a large amount of success in uncovering blood-specific and
semen-specific CpG sites (Lee et al., 2012; Madi et al., 2012), however, there have been
very few vaginal epithelial-specific and saliva-specific CpG sites located.
Methylation Analysis Methods
The level of methylation at a particular CpG site can be found using several
different methods such as ligation mediated PCR, restriction digestion PCR, and bisulfite
modification followed by pyrosequencing. Ligation mediated uses enzymes that are
methylation-sensitive to cut DNA sequences at restriction sites. The amount of enzyme
activity is quantitated by PCR amplification of the cleaved DNA pieces, which directly
correlates to the amount of methylation at the restriction site (McGrew & Rosenthal,
1993). For restriction digestion amplification a methylation-specific restriction enzyme is
used to cleave restriction sites where methylation is not present. Tissue identification
markers are amplified with the digested DNA and are fluorescently labeled. These PCR
products are measured by capillary electrophoresis; the loci with higher methylation
levels are going to amplify more efficiently and will give a greater signal (Frumkin et al.,
2011).
A more recent method of methylation analysis can be accomplished by using
bisulfite conversion techniques followed by pyrosequencing. The purpose of the bisulfite
modification is to convert all unmethylated cytosine bases in a genomic sample to uracil
while all the methylated cytosines remain as methylated cytosine (5mc). After the
5

modification, the DNA undergoes site-specific PCR amplification, followed by
pyrosequencing. The DNA samples are denatured to single-stranded DNA and are
exposed to a synthesized sequencing primer that anneals prior to samples entering the
sequencing process (Delaney, Garg, & Yung, 2015). The single-stranded DNA is then
synthesized, and with each incorporated nucleotide light is emitted and recorded. The
amount of guanine or Adenine that is incorporated at a specific CpG site gives
information about the amount of methylation present at that site in the sample being
tested (Delaney, Garg, & Yung, 2015). If the same approximate level of methylation is
seen at CpG sites across several samples, that methylation data can be compared to data
for the same CpG site in other tissue samples. For the purposes of tissue discrimination,
there needs to be a consistent trend of hypomethylation for one tissue while all others
remain hypermethylated and vice versa. Pyrosequencing technology is advantageous for
methylation analysis since it provides quantitative methylation data that can be used for
tissue to tissue comparison.
Aims and Objectives
The main objective of this study is to locate a set of CpG sites that contain
methylation levels consistent enough to discriminate saliva cells from other bio-fluids of
forensic interest such as blood, vaginal epithelial tissue, and sperm. Ideally, if these CpG
sites could be located for saliva, the data could be combined with methylation data for
other tissue types to develop an assay capable of identifying the tissue source of an
unknown DNA sample. Development of multiple markers for saliva identification will
reduce the error rate in tissue identification. Since the DNA is already available for
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forensic case work, there is no need to expend additional evidentiary item for this
analysis.
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CHAPTER II – REVIEW OF LITERATURE
Current Tissue Identification Methods
Currently, several presumptive and confirmatory tests exist as a whole for the
identification of forensically-relevant body fluids. While these tests have become
standard in many serological laboratories, they do have certain limitations. Many of
these serological methods lack in either specificity or sensitivity, which can lead to false
positive or false negative results.
Blood
One of the most common biological fluids found at crime scenes is blood. The
presumptive tests for blood can be divided into two categories, namely catalytic color test
and chemiluminescent test. The catalytic color test involves the change of color of the
reagent used while chemiluminesence and fluorescence tests both emit light as the end
product of an oxidation reaction in the presence of hemoglobin, a protein found in blood
(Cassidy et al., 2017). Chemiluminescence does not require an alternate light source to be
seen, however fluorescence tests do need an alternate light source to be visualized
(Vandewoestyne et al., 2015) The most commonly used chemiluminescence test is
Luminol, a presumptive test that has been found to have a sensitivity of detection for
blood samples diluted up to 1:100,000 (Tobe et al., 2007).
The two most common catalytic color tests are Hemastix and Phenolphthalein.
Both tests, as the name implies, produce a change in color that corresponds to the
possible presence of blood in a sample. In a study conducted by Vennemann et al. (2014)
the group was able to determine that the phenolphthalein presumptive test had a high
sensitivity for neat blood samples at a 1:10,000,000 dilution, but showed poor results
8

when testing for specificity of blood detection. Hemastix test strips that were developed
to detect occult blood in urine have found its way in forensic testing as well. A study
conducted by Tobe et al. (2007) showed a sensitivity for Hemastix up to 1:100,000, but
was unsuccessful in detecting blood at dilutions greater than this. The same group also
tested the specificity of Hemastix using a number of various foods, chemicals, and other
biological samples and found a large number of non-blood materials gave positive results
for the test (Tobe et al., 2007). In addition, both catalytic color presumptive tests have
been reported to cause DNA degradation (Thanakiatkrai et al., 2014). Since presumptive
positive blood samples will be submitted for further DNA analysis, the DNA degradation
should be kept to a minimum to the possible extent.
There are two serological tests that serve as confirmatory tests for the presence of
blood: Takayama Crystal Test and the use of an ABAcard Hematrace test kit. The
Takayama Crystal Test employs a Takayama reagent, which when added to a blood
sample will produce pink colored feather-shaped crystals called pyridine
ferroprotoporphyrin crystals that can be viewed under a microscope. This test is not
specific to humans, and therefore cannot be used as a species-specific test, but only a
confirmatory test. The most commonly used species-specific test for blood is the
ABAcard Hematrace test card. This card is a one-step chromatographic test that relies on
the specific reaction between human hemoglobin (Hb) antigens and anti-human
hemoglobin antibodies (Hurley et al., 2009). The ABAcard Hematrace is described as
having both high in specificity and sensitivity (Hurley et al., 2009), however it is not
species specific. The ABAcard Hematrace test has shown positive blood detection results
for human, primates, and ferrets (Johnston, Newman, & Frappier, 2003). The advantages
9

of this test do outweigh the disadvantages, as it is unlikely that the other species body
fluids will be found at a crime scene.
Semen
Another biological sample of forensic interest is semen, generally present in cases
where a sexual assault has taken place. Like other biological specimens, both a
presumptive test and a confirmatory test are used to ascertain the presence of semen or
spermatozoa. The presumptive test used for semen identification is called acid
phosphatase, and is a color test that identifies acid phosphatase, which is found in the
higher quantity in seminal fluid when compared to other secretions. In a study conducted
by Gonçalves et al. (2017), the group tested the specificity of acid phosphatase
presumptive test using semen and semen mixed with other biological fluids. It was found
that The AP test was effective in giving a positive result in the presence of diluted semen
samples, however was unsuccessful in discriminating between semen and other types of
biological samples (Gonçalves et al., 2017). Another limitation of the acid phosphatase
test is that the amount of acid phosphatase can vary largely between males (Redhead &
Brown, 2013). It has also been found that the storage temperatures of the evidence affect
the activity of acid phosphatase in the semen sample (Gaensslen 1983)
The two most commonly used confirmatory tests for semen identification are a
microscopic search of spermatozoa and the detection of a prostate-specific antigen (PSA)
using ABAcard p30 test strip. The identification of spermatozoa through a microscope
has no specificity concerns since the spermatozoa are physically observed by the analyst.
The only sensitivity concerns arise when there is a male individual who does not produce
any spermatozoa, but this is a rare occurrence.
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The ABAcard p30 test strip works for semen detection in the same way as the
ABAcard Hematrace test strip works for blood detection, through antigen-antibody
interactions. When a sample contains seminal material, the p30 antigen will bind with the
anti-p30 antibodies, causing the formation of a colored band in the test kit. The
previously mentioned study conducted by Gonçalves et al. (2017), also investigated
specificity and sensitivity of the kit for p30 antigens and found that the kit was highly
sensitive and specific for the p30 antigens, while other body fluids produced a negative
result. (Gonçalves et al., 2017).
Vaginal Epithelial tissue
While there are several serological techniques available for the identification of
blood and spermatozoa, there is no standard laboratory protocol exists for the
identification of vaginal epithelial tissue. Earlier methods used for the identification of
vaginal epithelial cells using glycogen staining were not reliable.
Saliva
Saliva contains an enzyme amylase that is present in higher quantities in saliva
than other body fluids, making it a prime candidate for possible saliva detection. While
the detection of saliva is neither a presumptive nor confirmatory test, the quantity of
amylase in the sample can be used to make conclusions regarding the presence or absence
of saliva in a sample. Amylase is a starch-hydrolyzing enzyme, used in conjunction with
an iodine that can stain starch a blue color (Meyers & Adkins, 2008). These two factors
are used together to determine the approximate quantity of amylase present in a sample.
This information is then compared to known saliva, and non-saliva reference samples to
determine the possible source of the unknown body fluid. One complication of using this
11

method is the interpretation of samples that are mixtures, which would have a varying
concentration of amylase when compared to neat samples. Other tests such as the RSIDsaliva identification kit determines the presence of the enzyme α-amylase in evidentiary
samples (Casey and Price, 2010)
DNA Methylation Analysis
Compared to the progress that has been made for blood and semen identification,
the literature regarding the identification of vaginal epithelial tissue and saliva are scanty.
There have been several cases that support the validity of using methylation analysis for
tissue identification. The first use of methylation analysis for forensic casework can be
seen through the work of Frumkin et al. (2010) when the group developed an assay for
the purpose of distinguishing artificial DNA from real DNA using methylation levels.
The overall goal of such an assay was to increase the integrity of forensic DNA analysis,
and as a result the group found that certain loci are consistently methylated where others
are unmethylated. This fact opened the door to the possibility of distinguishing various
forensically relevant tissue types using the same type of methylation analysis.
In 2011, Frumkin et al. published their work regarding the use of DNA
methylation levels to distinguish between tissue types. The group used 50 samples
including blood, semen, saliva, and skin cells that were first digested with a methylationspecific endonuclease, followed by amplification at specified regions and then analyzed
using capillary electrophoresis. Using this methodology, the group was able to identify
the source tissue for each sample tested using the methylation percentages obtained.
A study completed by Lee et al. (2011) further exemplified the ability to
distinguish tissue types from one another using DNA methylation analysis. The study
12

investigated five differentially methylated regions (tDMR) of the DNA for the following
sample types: saliva, blood, menstrual blood, vaginal fluid, and semen. Using bisulfite
conversion methods, the group was able to determine that two of the markers in question
were able to distinguish semen samples from all other tested sample types. Similarly, in a
study conducted by Madi et al. (2012), four methylation markers were used to
differentiate blood, saliva, and semen samples using pyrosequencing.

Methylation data

at these tDMRs are normally investigated using bisulfite modification of the genomic
DNA, site specific PCR amplification and pyrosequencing. Madi et al were able to
identify a panel of markers, C20orf117, ZC3H12D, BCAS4, and FGF7, that can be used
in the determination of blood, saliva, semen and skin epithelial cells. Both of the studies
presented by Lee et al. (2011) and Madi et al. (2012) show that investigating these
tDMRs provides a way to locate markers that can be used for tissue identification.
In a broad study conducted by Park et al. (2014) the group was able to identify a
large number of tDMRs using the Illumina HumanMethylation 450K bead array
technology. Using this data, they were able to generate a list of the tDMRs for four
different tissue types: saliva, blood, vaginal secretions, and semen. In addition to
publishing these potential sites Park et al. (2014) also investigated two sites for each of
the tissue type. They found that the eight selected sites possessed the ability to distinguish
each of the tissue type in question.
It has become increasingly clear that DNA methylation can be used to distinguish
tissue types from one another when the source of the sample is unknown. In a forensic
point of view identifying the tissue source of a DNA sample is important because the
presence or absence of a tissue may identify the type and severity of crime that took
13

place. Using the same bisulfite modification and pyrosequencing technology used by
Madi et al. (2012), we hope to identify a set of novel saliva-specific CpG markers using
potential candidate sites identified by Park et al. (2014).
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CHAPTER III - MATERIALS AND METHODS
Sample Collection
Samples of four types of biological fluids, blood, semen, vaginal epithelial cells,
and saliva were collected from volunteers under the conditions of an approved
Institutional Review Board (IRB) protocol at The University of Southern Mississippi. All
donor samples were assigned a unique identifier number to help maintain confidentiality
and anonymity of the samples.
Blood samples were collected by first sterilizing the donor’s fingertip with 70%
ethanol, and then pricking the finger with a sterile autolet lancet device. A sterile cotton
swab was used to absorb the blood sample, which was air dried, labeled with unique
number, and stored frozen at -20C.
The saliva samples were collected by swabbing the inside of the cheek of the
volunteer for approximately 30 seconds with a sterile cotton swab. The sample was air
dried, labeled with unique number, and stored frozen at -20C.
For semen sample collection, a sterile sample collection cup was provided to the
participants who collected the sample themselves in a manner that is private and
convenient to them. The donor then provided the sample to the researcher, who stored the
sample at -20C freezer.
The vaginal epithelial samples were collected on a sterile cotton swab by the
participant themselves in a manner that is convenient and comfortable to them. The
sample was then returned to the researcher, labeled with a unique number, and stored in a
-20C freezer.

15

DNA Extraction
DNA was extracted using organic extraction techniques (Budowle, 2000). Cotton
swabs containing samples of blood, saliva, or vaginal epithelial were separated from the
applicator stick and placed in a labeled 1.5 mL tube. Each reaction contained 400 mL of
stain extraction buffer, 10 microliters of Proteinase K, and was be incubated at 56°C
overnight. After the incubation period is complete, the cotton swab was transferred to a
new 1.5 mL tube containing a spin basket and centrifuged for five minutes at 12,000 rpm.
The flow-through was placed back into the original 1.5 mL tube and the spin basket
containing the cotton swab was discarded.
25 microliters of each semen sample was added to a tube that contained a
modified stain extraction cocktail; 150 microliters TNE (Tris/NaCl/EDTA), 50
microliters of 20% Sarkosyl, 40 microliters of 0.39M dithiothreitol, 150 microliters of
water, and 10 microliters of proteinase K solution and incubated at 37°C overnight.
Following incubation, 500 mL of phenol/chloroform/isoamyl alcohol was added
to each sample and briefly vortexed until a milky emulsion is obtained. Samples were
centrifuged for 10 minutes at 12,000 rpm to separate the aqueous and organic phases into
two distinct layers. The aqueous phase was removed from each sample, placed into a
concentrator, and then spun at 5,000 rpm for approximately ten minutes. Following this
initial spin, the flow-through was discarded and ~0.5 mL TE was added to the
concentrator. The samples were centrifuged for ten minutes at 5,000 rpm; the washing
steps were repeated three additional times for a total of four washes. The filter unit was
then inverted into a clean 1.5 mL tube and centrifuged at 3,000 rpm for approximately
three minutes. This DNA was stored at -20 °C until further testing.
16

DNA Quantitation
A 1% agarose gels was used to determine both the quantity and quality of the
extracted DNA. 1 μL of a 1Kb ladder was loaded into the well of each row in the agarose
gel. 2 μL of each sample combined with 2 μL of Bromophenol Blue (1:1 diluted) was
loaded into each well and electrophoresed in a 1x TAE buffer at 120V for twenty
minutes. The gel was stained for approximately 5 minutes in ethidium bromide and the
band intensities were photographed using a UV transilluminator. The band sizes and
intensity were compared to the standard ladder to determine the quantity and quality of
each DNA sample.
Bisulfite Conversion
Bisulfite conversions were performed using the recommended procedure provided
with the Qiagen EpiTect Bisulfite Kit. Approximately 200 ng of genomic DNA were
used for bisulfite conversion. The bisulfite conversation process is described below:
1. The components of each reaction for bisulfite conversion are listed in Table 1
below. Each component was added to a 0.2 mL tube
Component

Volume per reaction (µL)

DNA solution (1 ng-2 µg)

Variable* (maximum 20 µL)

Deionized water

Variable*

Bisulfite Mix solution

85

DNA Protect Buffer

35

Total volume

140

Table 1. Bisulfite conversion reaction components per sample
*The combined volume of DNA and water will total 20 microliters maximum
17

2. The samples were briefly vortexed, spun in the centrifuge, and placed in a
thermalcycler.

Stage
Duration (minutes)
Temperature (°C)
Denaturation 1
5
95
Incubation 1
25
60
Denaturation 2
5
95
Incubation 2
85
60
Denaturation 3
5
95
Incubation 3
120
60
Hold
Indefinite
20
Table 2. Thermocycler conditions for bisulfite conversion.
3. The program for bisulfite conversion is described in Table 2.
Cleaning the Bisulfite Converted DNA
1. Each sample was removed from the thermalcycler and the contents were
transferred to a clean 1.5 mL tube
2. 560 μL of loading buffer was added to the converted DNA, mixed and
centrifuged gently.
3. Samples were transferred to a spin column that is provided with the EpiTect
Bisulfite Kit and centrifuged at 12,000 rpm for 1 minute. The flow-through for
this spin was discarded.
4.

500 μL of wash buffer was added to each tube. The samples were spun for
one minute and the flow-through was discarded.

5. 500 microliters of desulfonation buffer was added to each tube, and incubated
at room temperature for 15 minutes. The samples were spun at 12,000 rpm for
one minute, and the flow through liquid was discarded.

18

6. 500 microliters of wash buffer was added to each sample and centrifuged for
one minute at 12,000 rpm, the liquid from the spin will be discarded. This step
was repeated a second time, providing the samples with two total washes with
the wash buffer.
7. The columns were moved to new 2 mL tubes, centrifuged at 12,000 rpm for 1
minute, and then incubated with open lids for 5 minutes at 56°C to promote
evaporation of the liquid.
8. The spin columns were placed in a new 1.5 mL tube and 20 μL of elution
buffer was added directly onto the column. After one minute of incubation at
room temperature, the samples were spun for one minute at 12,000 rpm. This
step was repeated once more by adding another 20 μL elution buffer before
centrifuging. The flow-through from these two spins contained the eluted
bisulfite converted DNA.
9. The 1.5 mL tubes were labeled and placed in the -20°C freezer until further
analysis.
Marker Selection and Primer Design
Park et al. (2014) has published the results of the Illumina 450k bead chip array
data that contains potential CpG markers for multiple tissue identification. Using this
data, several promising CpG sites for saliva identification were selected. The CpG site
location in the human genome was determined and the information was entered into the
University of California Santa Cruz (UCSC) genome browser. 200 base pairs of DNA
sequence both at the 5’ and 3’ of the CpG site were selected and downloaded from the
browser. This 400 base sequence was used to develop as assay for pyrosequencing using
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the Pyromark assay design software (Qiagen Inc.) Ideally, the overall PCR product
should be in the range of 100-200 base pairs.
Amplification of CpG Sites for Pyrosequencing
At least 10 samples of bisulfite converted DNA for each tissue type were selected
for PCR amplification. A PCR master mix was created as described in Table 3.
Bisulfite-converted DNA

2 µL

10x PCR Primer set

2 µL

Coral load solution

2 µL

Q-solution

4 µL

2x Master Mix

10 µL

Table 3. PCR components and corresponding volume for amplification per sample.
Samples, along with a negative control, were placed in the thermocycler and a PCR
amplification program was selected. This program is a cycling of three phases:
denaturation, annealing of primer, and extension, and is described in Table 4.
Initial

Denaturation Annealing Extension

Incubation Step
HOLD

Final

Final Soak

Extension
CYCLE (45 cycles)

HOLD

HOLD

95ºC

94ºC

Tm-5ºC

72ºC

72ºC

4ºC

15 min

30 sec

30 sec

30 sec

10 min

∞

Table 4. Thermalcycler conditions for polymerase chain reaction amplification.
To determine the success of amplification, a 2% agarose gel was used. A 100 bp ladder
was loaded in the leftmost well of each row followed by 2µl of samples, and was
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electrophoresed at 120 volts for 20 minutes in a 1x TAE buffer. The gel was stained in
ethidium bromide solution and a UV transilluminator was used to visualize and
photograph the gel.
Pyrosequencing
To begin pyrosequencing, an assay was created using Pyromark Q24 software.
The same software was used to determine the amount of enzyme, substrate, and dNTPs to
be added to the cartridge for the sequencing reaction.
A cocktail containing 2 microliters of streptavidin beads, 20 microliters of water,
and 40 microliters of binding buffer per sample was made. 62 microliters of cocktail was
added to each well of a 24-well plate, along with 18 microliters of PCR product. The
sample wells were covered with a strip cap and shaken at 1000 rpm for 10 minutes. The
24-well plate was removed from the shaker and the samples were processed using a
vacuum workstation. The vacuum work station was used to lift the samples, washed with
70% ethanol, denatured in NaOH solution and neutralized. After processing, the samples
were released into a pyrosequencing plate that contains 25 microliters of 1x sequencing
primer in each well. The pyrosequencing plate was incubated for two minutes at 80°C,
followed by 10 minutes at room temperature for annealing of the sequencing primers to
the target.
The pyrosequencing cartridge was prepared according to the quantities
determined in the pre-run information from the Pyromark Q24 software. Following the
addition of all materials to the pyrosequencer, the samples were ready to be sequenced.
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Pyrosequencing Data Analysis
Methylation data from the pyrosequencer was presented as a pyrogram, showing
relative methylation percentages at each CpG site within the target region. This data was
imported to an excel workbook where preliminary analysis was conducted regarding the
average percent methylation at each site as well as the standard deviation. A histogram
was created for each marker that includes the data from all four tissue types. Those sites
that look promising for saliva differentiation were analyzed further using SPSS statistical
analysis package software for the level of significance of the methylation data from
different tissues. A one-way ANOVA was used to compare the mean methylation levels
of different tissues. A p value of 0.05 or below (p<0.05) was considered significant.
Species Specificity Test
The species specificity study involves testing of non-human samples using PCR
and pyrosequencing. Several different species were tested using marker cg-9652652. The
samples tested were cat, dog, chicken, cow, erythrobacter, chimp, rhesus, and a human
control buccal sample. All genomic DNA samples were quantitated either by agarose gel
or by human DNA quantifiler kit (Applied Biosystems), bisulfate modified and PCR
amplified using the primers for the marker cg-9652652. The robustness of the
amplification was tested using a 2% agarose gel. All samples were sequenced by
pyrosequencing and the data was analyzed to determine if any species showed
quantifiable methylation data
Mixture study
For the mixture study one semen sample and one saliva sample were used. The saliva
sample had hypermethylation and semen sample was hypomethylated. The two samples
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chosen were based on success of previous PCR amplifications. Each sample was diluted
to a concentration of 10 ng/µl using TE buffer. Five different ratios of saliva v/s semen
were set up, which include 90-10, 72-25, 50-50, 25-75 and 10-90. Each ratio contained a
total combined amount of 100 ng of DNA, and was conducted in duplicate. After the
mixture was created, the samples were bisulfite modified followed by and PCR
amplification. A 2% gel was used to determine the success of the PCR amplification
followed by pyrosequencing. The data for these mixtures were averaged and analyzed for
any significant patterns.

23

CHAPTER IV – RESULTS
The genomic DNA quantitation using agarose gel was performed to assess the
quantity and quality of the DNA extracted from all tissues followed by bisulfate
conversion, PCR and pyrosequencing. Ten or more samples per tissue type were used for
pyrosequencing. The methylation analysis includes the average methylation of each CpG
sites for each tissue types.
Marker cg-9652652
For the marker cg-9652652, ten or more samples per tissue type were used for
methylation analysis. The methylation percentages for all CpG sites were analyzed using
excel program. The average and standard deviation data are shown in table 5.
CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

CpG_6

Buccal

61.0 14.6

52.4  11.5

53.9  55.1

55.1  13.9

49.3  8.9

60.3  15.9

Blood

14.8  14.5

12.5  11.6

12.5  12.4

14.4  15.1

11.1  10.4

13.7  14.3

V. Epi

12.5  13

10.0  10.7

9.5  11.0

10.8  11.8

10.5  10.3

11.0  10.7

Sperm

2.7  2.2

2.3  1.7

2.0  1.6

2.3  1.9

3.5  3.1

2.3  1.7

Table 5. Percent Methylation and Standard Deviation for cg-9652652
The same methylation data are shown as a histogram in figure 1.
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Average Percent Methylation

cg-9652652
80.0
70.0
60.0

Buccal

50.0

Blood

40.0

V. Epi

30.0

Sperm

20.0
10.0
0.0
CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

CpG_6

CpG Site
Figure 1. Histogram of average methylation data of marker cg-9652652. n=12 buccal; 10
blood; 11 v.epi; 12 sperm.
The level of significance (p<0.05) in the methylation data between different
tissues were calculated using SPSS statistical package with one-way ANOVA and
tukey’s posthoc parameters. It was found that the methylation data for all CpG sites were
significantly different (p = 0) compared to other tissues.
Marker cg-11536474
The average methylation data for the marker cg-11536474 for the four tissues
studied are shown in table 6.
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CpG_1

CpG_2

CpG_3

Buccal

76.6  18.9

72.8  20.9

69.2  20.1

Blood

10.4  8.4

10.5  12.1

8.1  8.5

V. Epi

10.1  3.6

12.2  4.3

8.5  2.9

Sperm

7.3  8.2

8.0  5.8

3.2  2.3

Table 6. Percent Methylation and Standard Deviation for cg-11536474
Figure 2 shows the methylation data for the four tissues for marker cg-11536474.

Average Percent Methylation

cg-11536474
100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

Buccal
Blood
V. Epi
Sperm

CpG_1

CpG_2
CpG Site

CpG_3

Figure 2. Histogram of the average methylation data of marker cg-11536474. n=12
buccal; 18 blood; 11 v.epi; 12 sperm.
It was found that the methylation data for all CpG sites were significantly
different (p = 0) compared to other tissues. This data suggests that the marker cg11536474 can be used to differentiate saliva from other tissues in forensic tissue
identification.
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Marker cg-3867465
The average methylation data for the marker cg-3867465 for the four tissues
studied are shown in table 7.

Buccal

CpG_1

CpG_2

47.6  11

54.4  13

CpG_3

CpG_4

74.5 

72.4 

15.7

14.7

CpG_5

68.4  14.6

Blood

4.1  2.2

5.6  2.6

10.1  5

9.8  5.2

6.0  1.7

V. Epi

3.6  1.5

5.3  4.1

9.5  7.2

10.1  5.3

9.6  4.7

Sperm

2.1  0.8

2.2  1.1

3.9  1.7

5.6  2.9

6.5  3.3

Table 7. Percent Methylation and Standard Deviation for data for cg-3867465
Figure 3 shows the methylation data for the four tissues for marker cg-3867465.

Average Methylation Percentage

Cg3867465
100.0
90.0
80.0

70.0
60.0

Buccal

50.0

Blood

40.0
30.0

V. Epi

20.0

Sperm

10.0
0.0

CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

CpG Site
Figure 3. Histogram of average methylation data of marker cg-3867465. n=11 buccal; 10
blood; 11 v.epi; 11 sperm.
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It was found that the methylation data for all CpG sites were significantly
different (p = 0) compared to other tissues. This data suggests that the marker cg3867465 can be used to differentiate saliva from other tissues in forensic tissue
identification.
Marker cg-10781408
The average methylation data for the marker cg-10781408 for the four tissues
studied are shown in tables 8.1 and 8.2.
CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

CpG_6

Buccal

72.0  18.9

75  19

68  20.2

77  19.8

52.5  17.6

56.0  17.5

Blood

3.4  2.5

2.3  1.8

2.3  2

2.5  0.8

4  1.8

1  0.7

V. Epi

16  6.7

15.2  6.7

12.6  6

18.4  7.4

16.8  5.7

11.3  5.1

Sperm

5.8  4.5

4.3  2.2

3.9  3.3

4.8  3.2

15.3  9.6

3.8  2.1

Table 8.1. Percent Methylation and Standard Deviation for cg-10781408 sites 1-6
CpG_7

CpG_8

CpG_9

CpG_10

CpG_11

Buccal

52  16.2

56  16.9

52  16.6

60  18.4

62.0  18.7

Blood

3  1.7

2.5  0.8

7.0  3.1

4.0  1.4

3.0  1.1

V. Epi

12  5.1

12.5  5.4

14.6  6.3

12.6  6.4

14.5  6

Sperm

5.6  3.4

7.5  2.7

8.0 3.4

6.5  3.9

6.5  3

Table 8.2. Percent Methylation and Standard Deviation for cg-10781408 sites 7-11
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Figure 4 shows the methylation data for the four tissues for marker cg-10781408.

cg-10781408
120

Average Percent Methylation

100

80

60

Buccal
Blood
V. Epi

40

Sperm
20

0

CpG Site
Figure 4. Histogram of average methylation data of marker cg-3867465. n=12 buccal; 11
blood; 11 v.epi; 12 sperm.
It was found that the methylation data for all CpG sites were significantly
different (p = 0) compared to other tissues. This data suggests that the marker cg10781408 can be used to differentiate saliva from other tissues in forensic tissue
identification.
Marker cg-10122865
The average methylation data for the marker cg-10122865 for the four tissues
studied are shown in table 9.
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CpG_1
Buccal

CpG_2

CpG_3

CpG_4

CpG_5

85.6  21.4 65.9  18.5 73.4  18.8 58.7  17.2 75.1  21.4

Blood

7.2  2.4

5.2  1.6

2.6  1.9

3.5  4.1

5.8  3.2

V. Epi

15.4  7.8

11.3  6

9.8  8.3

8.1  5.8

13.7  6.1

Sperm

7.0  4.4

12.4  9

3.4  2.3

4.5  4

13.3  7.9

Table 9. Percent Methylation and Standard Deviation for cg-10122865

Average Methylation Percentage

cg-10122865
100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

Buccal
Blood
V. Epi
Sperm

CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

CpG site

Figure 5. Histogram of average methylation data of marker cg-10122865. n=11 buccal;
11 blood; 11 v.epi; 12 sperm.
It was found that the methylation data for all CpG sites were significantly
different (p = 0) compared to other tissues. This data suggests that the marker cg10122865 can be used to differentiate saliva from other tissues in forensic tissue
identification.
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Species Test
In order to know the specificity of the primers to see if any other species will react
with the human assay, several other organisms were tested. For this purpose, the
following samples were tested: cat, dog, chicken, cow, erythrobacter, chimp, and rhesus.
When amplified for the marker cg9652652, only the chimp, and rhesus samples amplified
that was detected with a 2% agarose gel. All samples used in the amplification were
sequenced regardless of amplification success. Tables 10.1 and 10.2 show the
methylation data obtained from different species.
CpG_1

CpG_2

CpG_3

CpG_4

CpG_5

Chimp

6

2

2

3

1

Rhesus

85

76

82

94

84

BUC 147

88

75

73

80

59

Table 10.1 Methylation data obtained for the different species, sites 1-5

CpG_6

CpG_7

CpG_8

CpG_9

Chimp

2

7

7

2

Rhesus

3

3

5

95

BUC 147

77

58

78

84

Table 10.2 Methylation data obtained for different species, sites 6-9
The chimp sample was hypermethylated in all CpG sites tested while the rhesus
sample produced mixed results, with CpG sites 1-5 and 9 being hypermethylated, and site
6-8 hypomethylated. All other species tested did not produce any methylation data. These
results show that the primers are human specific and can be used to identify human
tissues in a forensic scenario.
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Mixture Study
Often the samples submitted for forensic analysis are mixtures of two different
individuals or samples of two different tissues. To study how a sample with two different
body fluids mixed will behave in pyrosequencing, mixtures of two different body fluid
DNA were prepared in different ratios (buccal versus sperm %): 90-10, 72-25, 50-50, 2575, and 10-90. All samples showed amplification bands of the right size and were
pyrosequenced. The methylation data of the different ratios for CpG site 2 in marker cg9652652 is shown in Figure 6. As expected, the methylation increased when the saliva
sample is predominant and decreased when the sperm sample is predominant.

Average Percent Methylation

cg-9652652 Mixture Study
60
50
40
30
20
10
0
100-0

90-10

72-25

50-50

25-75

10-90

0-100

Ratio (Percent Saliva-Percent Semen)

Figure 6. Methylation percent averages of mixed samples for cg-9652652, CpG site 2.
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CHAPTER V – DISCUSSION
Tissue identification in a forensic setting may provide vital information about the
type and severity of a crime that has taken place. Coupled with DNA analysis,
information could be gained that may determine the individual(s) who were present at the
scene. The use of methylation analysis has received more attention in the recent decade
as an alternate option for tissue identification (Frumkin et al., 2010; Frumkin et al., 2011;
Lee et al., 2012; Madi et al., 2012; Park et al., 2014). DNA Methylation is an epigenetic
process that can alter the gene function without changing the underlying DNA sequence
itself. In previous years, DNA methylation has been studied for medicinal purposes, as
methylation site proximity to the promotor region of genes control gene regulation. (Li
& Zhang, 2012; Previti et al., 2009). It has been determined that using bisulfite
conversion followed by PCR and pyrosequencing can provide quantitative methylation
levels of a CpG site. Pyrosequencing is a process that provides a ratio of converted to
unconverted cytosine bases in a CpG site to determine the percent methylation of that site
in question. The same analytical technique has been applied in the identification of four
forensically-relevant tissue types: blood, semen, saliva, and vaginal epithelial tissue. Lee
et al. (2012) and Madi et al. (2012) have used this pyrosequencing technology to study
the methylation data for the identification of different tissues. In spite of the success of
this technology, data regarding the identification of other tissues such as vaginal
epithelial tissue and saliva are rare.
Therefore, this present study was undertaken to determine the usefulness of
methylation data in differentiating saliva from three other forensically relevant tissues
such as blood, semen and vaginal epithelia. In a study conducted by Park et al., (2014),
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the investigators located a large number of potential CpG sites that can differentiate
saliva from other tissues using Illumina 450K bed chip array technology. This
preliminary data was used to study certain saliva specific markers that may be used for
the differentiation of saliva from other tissues.
Saliva identification:
Several potential CpG sites mentioned by Park et al (2014) were screened and
five methylation markers were identified which showed promise in the differentiation of
saliva from the other tissues. The identified markers were cg9652652, cg11536474,
cg3867465, cg10781408, and cg10122865 along with additional CpG sites that flank
these sites.
All the five markers mentioned above showed hypermethylation in saliva while
the other tissues were hypomethylated. The percent methylation levels between saliva
and all other tissue types were found to be statistically significant (p<0.05) for all five
markers tested, giving the conclusion that these five markers could be used to
differentiate saliva from blood, semen, and vaginal epithelial samples.
Species specificity of the markers:
In a forensic setup, identification of the species of origin of a tissue sample is
important since the unknown crime scene samples may contain non-human DNA. To
determine if the assay developed for the markers are human specific, one of the markers
studied (cg9652652) was chosen to determine if non-human samples will amplify and
provide any methylation data. Several different species were tested including cat, dog,
chicken, cow, erthyrobacter, chimp, rhesus, and a human control. All samples were
analyzed using pyrosequencing and only the chimp and rhesus samples gave usable
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methylation data. It is not unexpected that the two primate samples amplified with the
human specific primers because of the high similarity of the primate genome with that of
humans. All other non-primate samples did not produce any methylation data and this
proves that the PCR primers used in this study are human specific and will not interfere
with non-human DNA samples.
Mixture studies:
It is often possible that the DNA samples recovered from crime scenes are either
mixture of two different individuals or of two different cell types. In order to study how a
sample with two different cell type mixture behaves in their methylation content, a
controlled mixture of two different cell types and of different ratios were studied. A
sperm sample that was hypomethylated and a saliva sample that was hypermethylated
were used. As theoretically expected, when the quantity of saliva was reduced, the
methylation percent of the mixture also was reduced. These mixture studies help in
deciphering of different components and quantity of each tissue type.
In addition to tissue identification, other studies have attempted to correlate the
age of an individual and methylation (Weidner et al., 2014; Park et al., 2016; Alghanim et
al., 2017). Some studies have reported the success in differentiating different age group
individuals with methylation data (Jenkins et al., 2014, Vidaki et al., 2016). The ability to
estimate age in a forensic setting when the source of a tissue sample is unknown would
have significant implications.
Using methylation analysis for tissue identification over traditional serological
tests has several advantages. First, traditional serological tests are used presumptively to
determine if additional testing is warranted. Additional tests can lead to the consumption
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of evidentiary material. For methylation analysis, the analyst does not have to extract the
DNA separately because the DNA is already available for case work analysis.
Most traditional serological tests rely on the specific interaction of proteins within
the tissue in question and the chemicals used for testing. The second advantage of
methylation analysis for tissue differentiation is that this test relies on DNA, which is
more stable that the protein used in serological analysis, and the proteins can degrade
over a period of time. Third, there is also a potential for multiplex kit development where
more than one marker can be analyzed simultaneously either for tissue identification or
age determination or a combination of both. This would reduce the cost associated with
individual marker analysis.
Limitations of this study include the influence of external factors such as age,
smoking, diet, and obesity. It has been reported that factors such as smoking and obesity
contribute to the methylation status of an individual (Vidaki et al., 2013). So, it should be
kept in mind that external factors can contribute to the differences in methylation among
the experimental population.
In conclusion, it is determined that the five markers identified in this study have
the potential to differentiate saliva from other forensically relevant tissues. Also, the
primers used in the assay appear to be human specific with no interference of nonprimate samples.
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APPENDIX A – Primer Specifications

Marker

Primer Sequence

PCR
Product
Size

Forward: GAGTTTTATTAGGGTTGAGTTTTT
Cg9652652

Reverse: CCCCAAATACCCCATTTCC

125 bp

Sequencing: AGTTTTATTAGGGTTGAGTTTTTT

Forward: GAGTTAGGTTGTAGTAAAGTTT
Cg11526474

Reverse: ACTACCCCCCTATAAACCTCTAC
Sequencing: GAGTTAGGTTGTAGTAAAGTTTT

129 bp

Forward TTTGGAGAGTTGAGTATTTGTGTGGTAAG
Cg3867465

Reverse: ACCTCTAACCCCTCTCAACAAACTCTAC
Sequence: TGGTAAGAGGGGTTT

150 bp

Forward: GTAGTATAGGAAGTTTAGGTGGAAGA
Cg10781408

Reverse: ATCCAAACCTCACTCTCTATCC
Sequencing: AGTTTAGGTGGAAGAG

118 bp

Forward: GGGGGTTAGGAGAGTTTAAGA
Reverse: ACACCAAACCACCTTTTCT
Cg10122865

Sequencing: AGTTTAAGAAGTGGGG
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111 bp
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